Skip to Main Content

Author Details

Susan Geyer
Division of Clinical Trials and Biostatistics, Mayo Clinic
2001
146
55
PMIDPaper TitleJournal TitlePublished Year
36215675Graded Cardiac Response Criteria for Patients With Systemic Light Chain Amyloidosis.J Clin Oncol2023
37493986Mutations associated with progression in follicular lymphoma predict inferior outcomes at diagnosis: Alliance A151303.Blood Adv2023
37188699Conditional survival in multiple myeloma and impact of prognostic factors over time.Blood Cancer J2023
36990614Current drug development and trial designs in neuro-oncology: report from the first American Society of Clinical Oncology and Society for Neuro-Oncology Clinical Trials Conference.Lancet Oncol2023
36288512Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic <i>NF2</i> Mutations.J Clin Oncol2023
35053576The Alliance AMBUSH Trial: Rationale and Design.Cancers (Basel)2022
35349669Effect of additional cytogenetic abnormalities on survival in arsenic trioxide-treated acute promyelocytic leukemia.Blood Adv2022
35664553Phase I/randomized phase II trial of TRC105 plus bevacizumab versus bevacizumab in recurrent glioblastoma: North Central Cancer Treatment Group N1174 (Alliance).Neurooncol Adv2022
35524749Oral Glucose Tolerance Test Measures of First-phase Insulin Response and Their Predictive Ability for Type 1 Diabetes.J Clin Endocrinol Metab2022
35484400KDR genetic predictor of toxicities induced by sorafenib and regorafenib.Pharmacogenomics J2022
35938646Abnormal CD13/HLA-DR Expression Pattern on Myeloblasts Predicts Development of Myeloid Neoplasia in Patients With Clonal Cytopenia of Undetermined Significance.Am J Clin Pathol2022
35882836Distribution of clonal hematopoiesis of indeterminate potential (CHIP) is not associated with race in patients with plasma cell neoplasms.Blood Cancer J2022
35880956Index60 Is Superior to HbA1c for Identifying Individuals at High Risk for Type 1 Diabetes.J Clin Endocrinol Metab2022
34853027Index60 Identifies Individuals at Appreciable Risk for Stage 3 Among an Autoantibody-Positive Population With Normal 2-Hour Glucose Levels: Implications for Current Staging Criteria of Type 1 Diabetes.Diabetes Care2022
35175355Clinical activity of single-dose systemic oncolytic VSV virotherapy in patients with relapsed refractory T-cell lymphoma.Blood Adv2022
34326068<i>TCF7L2</i> Genetic Variants Do Not Influence Insulin Sensitivity or Secretion Indices in Autoantibody-Positive Individuals at Risk for Type 1 Diabetes.Diabetes Care2021
33654204Midostaurin reduces relapse in FLT3-mutant acute myeloid leukemia: the Alliance CALGB 10603/RATIFY trial.Leukemia2021
32452601Phase I Study of Veliparib on an Intermittent and Continuous Schedule in Combination with Carboplatin in Metastatic Breast Cancer: A Safety and [18F]-Fluorothymidine Positron Emission Tomography Biomarker Study.Oncologist2020
31668825Geriatric assessment among older adults receiving intensive therapy for acute myeloid leukemia: Report of CALGB 361006 (Alliance).J Geriatr Oncol2020
32037935Phase I study of AR-42 and decitabine in acute myeloid leukemia.Leuk Lymphoma2020
32092139Combination of dasatinib with chemotherapy in previously untreated core binding factor acute myeloid leukemia: CALGB 10801.Blood Adv2020
33049054Midostaurin in patients with acute myeloid leukemia and FLT3-TKD mutations: a subanalysis from the RATIFY trial.Blood Adv2020
30658992A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403.Blood2019
30725205A pilot study of interferon-alpha-2b dose reduction in the adjuvant therapy of high-risk melanoma.Cancer Immunol Immunother2019
30393935Outcome for pediatric acute promyelocytic leukemia patients at Children's Oncology Group sites on the Leukemia Intergroup Study CALGB 9710 (Alliance).Pediatr Blood Cancer2019
29324175Radiation- and Age-Associated Changes in Peripheral Blood Dendritic Cell Populations among Aging Atomic Bomb Survivors in Japan.Radiat Res2018
35135123Phase I Trial of Dabrafenib and Pazopanib in <i>BRAF</i> Mutated Advanced Malignancies.JCO Precis Oncol2018
30083962Phase II randomized, double-blind, placebo-controlled study of tivantinib in men with asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer (mCRPC).Invest New Drugs2018
30274868Impact of early life exposure to ionizing radiation on influenza vaccine response in an elderly Japanese cohort.Vaccine2018
27624549Maintenance therapy with decitabine in younger adults with acute myeloid leukemia in first remission: a phase 2 Cancer and Leukemia Group B Study (CALGB 10503).Leukemia2017
28082441Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era.Blood2017
28319462Late Effects of Exposure to Ionizing Radiation and Age on Human Thymus Morphology and Function.Radiat Res2017
29296854Cyclosporine or steroids as an adjunct to plasma exchange in the treatment of immune-mediated thrombotic thrombocytopenic purpura.Blood Adv2017
29189104Radiation- and Age-Associated Changes in Peripheral Blood Dendritic Cell Populations among Aging Atomic Bomb Survivors in Japan.Radiat Res2017
28644114Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation.N Engl J Med2017
28817373Cabozantinib As Salvage Therapy for Patients With Tyrosine Kinase Inhibitor-Refractory Differentiated Thyroid Cancer: Results of a Multicenter Phase II International Thyroid Oncology Group Trial.J Clin Oncol2017
25068471Treatment-related Hypertension as a Pharmacodynamic Biomarker for the Efficacy of Bevacizumab in Advanced Pancreas Cancer: A Pooled Analysis of 4 Prospective Trials of Gemcitabine-based Therapy With Bevacizumab.Am J Clin Oncol2016
26514544Impact of TP53 mutation variant allele frequency on phenotype and outcomes in myelodysplastic syndromes.Leukemia2016
26526191Relationship between obesity and clinical outcome in adults with acute myeloid leukemia: A pooled analysis from four CALGB (alliance) clinical trials.Am J Hematol2016
26256940Atorvastatin for the Prophylaxis of Acute Graft-versus-Host Disease in Patients Undergoing HLA-Matched Related Donor Allogeneic Hematopoietic Stem Cell Transplantation (allo-HCT).Biol Blood Marrow Transplant2016
27833082Discovery and replication of microRNAs for breast cancer risk using genome-wide profiling.Oncotarget2016
27291293Erratum to "Granulocyte Colony-Stimulating Factor-Mobilized Allografts Contain Activated Immune Cell Subsets Associated with Risk of Acute and Chronic Graft-versus-Host Disease" [Biol Blood Marrow Transplant 22(2016):658-668].Biol Blood Marrow Transplant2016
27521316Increased Levels of Plasma Epstein Barr Virus DNA Identify a Poor-Risk Subset of Patients With Advanced Stage Cutaneous T-Cell Lymphoma.Clin Lymphoma Myeloma Leuk2016
26719427Systemic Immune Activity Predicts Overall Survival in Treatment-Naïve Patients with Metastatic Pancreatic Cancer.Clin Cancer Res2016
26743340Granulocyte Colony-Stimulating Factor-Mobilized Allografts Contain Activated Immune Cell Subsets Associated with Risk of Acute and Chronic Graft-versus-Host Disease.Biol Blood Marrow Transplant2016
27039845Randomized Phase 2 Trial of the Oncolytic Virus Pelareorep (Reolysin) in Upfront Treatment of Metastatic Pancreatic Adenocarcinoma.Mol Ther2016
27102155Long term effects of radiation exposure on telomere lengths of leukocytes and its associated biomarkers among atomic-bomb survivors.Oncotarget2016
26970120The Bayesian basket design for genomic variant-driven phase II trials.Semin Oncol2016
26784138Midostaurin, bortezomib and MEC in relapsed/refractory acute myeloid leukemia.Leuk Lymphoma2016
26892479Clinical impact of ABL1 kinase domain mutations and IKZF1 deletion in adults under age 60 with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL): molecular analysis of CALGB (Alliance) 10001 and 9665.Leuk Lymphoma2016
  • 1 - 50 of 146

Recommended Authors

Zhengming Chen
Weill Cornell Medicine and New York Presbyterian Hospital
Career Start Year 2013
Number of shared co-authors 0
Shalin Kothari
Yale University
Career Start Year 2013
Number of shared co-authors 0
Srinivas K Tantravahi
Huntsman Cancer Institute at the University of Utah.
Career Start Year 2012
Number of shared co-authors 2
Andy Kaempf
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 2011
Number of shared co-authors 1
Sameer A Parikh
Mayo Clinic
Career Start Year 2010
Number of shared co-authors 6
Prapti Patel
The University of Texas Southwestern Medical Center
Career Start Year 2009
Number of shared co-authors 5
Lina Benajiba
Universite de Paris, Inserm CIC 1427
Career Start Year 2009
Number of shared co-authors 4
Milos D Miljkovic
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2009
Number of shared co-authors 3
Geoffrey Shouse
City of Hope National Medical Center
Career Start Year 2007
Number of shared co-authors 0
Aarthi Shenoy
MedStar Washington Hospital Center
Career Start Year 2006
Number of shared co-authors 0
Stephen E Spurgeon
Knight Cancer Institute, Oregon Health and Science University
Career Start Year 2006
Number of shared co-authors 1
Alexey V Danilov
City of Hope National Medical Center
Career Start Year 2005
Number of shared co-authors 1
Marlise R Luskin
Dana-Farber Cancer Institute
Career Start Year 2005
Number of shared co-authors 10
Ronan Swords
Oregon Health and Science University
Career Start Year 2004
Number of shared co-authors 5
Tara L Lin
University of Kansas Medical Center
Career Start Year 2004
Number of shared co-authors 3
Pingfu Fu
Case Western Reserve University
Career Start Year 2000
Number of shared co-authors 2
David J Liewehr
Center for Cancer Research
Career Start Year 1999
Number of shared co-authors 0
David M Weinstock
Merck & Co.
Career Start Year 1998
Number of shared co-authors 7
Andrew M Evens
Rutgers Robert Wood Johnson Medical School
Career Start Year 1998
Number of shared co-authors 4
Eric Tse
School of Clinical Medicine, University of Hong Kong
Career Start Year 1997
Number of shared co-authors 1
Farhad Ravandi
University of Texas M.D. Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 10
David A Rizzieri
Duke University Medical Center
Career Start Year 1995
Number of shared co-authors 6
Bijal Shah
Moffitt Cancer Center
Career Start Year 1992
Number of shared co-authors 2
Peter Westervelt
Washington University School of Medicine
Career Start Year 1990
Number of shared co-authors 12
Suzanne Trudel
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1990
Number of shared co-authors 0
Seth M Steinberg
Center for Cancer Research, National Cancer Institute
Career Start Year 1984
Number of shared co-authors 3
Richard T Maziarz
Oregon Health & Science University
Career Start Year 1983
Number of shared co-authors 2
Hagop Kantarjian
The University of Texas MD Anderson Cancer Center
Career Start Year 1982
Number of shared co-authors 16
Kenneth C Anderson
Dana Farber Cancer Institute
Career Start Year 1981
Number of shared co-authors 8
Ulrich D??hrsen
University Hospital Essen, University of Duisburg-Essen
Career Start Year 1979
Number of shared co-authors 1

Collaborators

Rafael Fonseca
Co-authored papers 15
Sundararajan Vincent Rajkumar
Co-authored papers 14
Tait D Shanafelt
Stanford Cancer Institute, Stanford University
Co-authored papers 13
Richard M Stone
Dana Farber Cancer Institute
Co-authored papers 11
Martin S Tallman
Memorial Sloan-Kettering Cancer Center
Co-authored papers 7
Craig C Hofmeister
Co-authored papers 5
Krzysztof Mr??zek
The Ohio State Comprehensive Cancer Center
Co-authored papers 4
Scott H Kaufmann
Mayo Clinic
Co-authored papers 4
Jeff A Sloan
Mayo Clinic
Co-authored papers 3
Charles F Lynch
Co-authored papers 3
Caterina Giannini
Mayo Clinic
Co-authored papers 3
Bruno C Medeiros
AbbVie Inc.
Co-authored papers 3
Wendy Cozen
Co-authored papers 3
Dietger Niederwieser
University of Leipzig
Co-authored papers 3
Peter Leif Bergsagel
Co-authored papers 3
Charles G Mullighan
St Jude Children's Research Hospital
Co-authored papers 2
Shubham Pant
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
Kristin Greathouse
Masonic Children's Hospital
Co-authored papers 2
Priya Kumthekar
Northwestern University, Feinberg School of Medicine
Co-authored papers 2
Ann-Kathrin Eisfeld
The Ohio State University Comprehensive Cancer Center
Co-authored papers 2
Suresh Nair
Lehigh Valley Topper Cancer Institute
Co-authored papers 2
Stephen J Chanock
National Cancer Institute, National Institutes of Health
Co-authored papers 2
David Schiff
University of Virginia School of Medicine
Co-authored papers 2
Jyotsna Nateri
Center for Clinical and Translational Research, Nationwide Children's Hospital
Co-authored papers 2
Priscilla K Brastianos
Co-authored papers 2
Patrick Y Wen
Co-authored papers 2
Mark W Hall
Nationwide Children's Hospital, The Ohio State University
Co-authored papers 2
Jill M Ferdinands
Centers for Disease Control and Prevention
Co-authored papers 1
Obi L Griffith
Washington University
Co-authored papers 1
Sholom Wacholder
National Cancer Institute
Co-authored papers 1
Release 1.2